Xu Y - Search Results

1

Tuning Surface Valences of Nanoengagers to Enhance Their Structural Advantages for Efficiently Redirecting T Cells against Solid Tumors.

Huang Z, Liu L, Zhu Z, Wang S, Zhao J, Ma S, Si X, Xu Y, Wu F, Song W, Chen X. Huang Z, et al. Among authors: xu y. ACS Nano. 2025 Jan 14;19(1):381-395. doi: 10.1021/acsnano.4c08293. Epub 2025 Jan 3. ACS Nano. 2025. PMID: 39750529

2

Neutralizing tumor-promoting inflammation with polypeptide-dexamethasone conjugate for microenvironment modulation and colorectal cancer therapy.

Ma S, Song W, Xu Y, Si X, Zhang D, Lv S, Yang C, Ma L, Tang Z, Chen X. Ma S, et al. Among authors: xu y. Biomaterials. 2020 Feb;232:119676. doi: 10.1016/j.biomaterials.2019.119676. Epub 2019 Dec 16. Biomaterials. 2020. PMID: 31896516

3

Rationally Designed Polymer Conjugate for Tumor-Specific Amplification of Oxidative Stress and Boosting Antitumor Immunity.

Ma S, Song W, Xu Y, Si X, Lv S, Zhang Y, Tang Z, Chen X. Ma S, et al. Among authors: xu y. Nano Lett. 2020 Apr 8;20(4):2514-2521. doi: 10.1021/acs.nanolett.9b05265. Epub 2020 Mar 4. Nano Lett. 2020. PMID: 32109068

4

In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy.

Zhao J, Ma S, Xu Y, Si X, Yao H, Huang Z, Zhang Y, Yu H, Tang Z, Song W, Chen X. Zhao J, et al. Among authors: xu y. Biomaterials. 2021 Jan;268:120542. doi: 10.1016/j.biomaterials.2020.120542. Epub 2020 Nov 21. Biomaterials. 2021. PMID: 33249316

5

Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer Immunotherapy.

Zhang Y, Ma S, Liu X, Xu Y, Zhao J, Si X, Li H, Huang Z, Wang Z, Tang Z, Song W, Chen X. Zhang Y, et al. Among authors: xu y. Adv Mater. 2021 Feb;33(7):e2007293. doi: 10.1002/adma.202007293. Epub 2021 Jan 14. Adv Mater. 2021. PMID: 33448050

6

Biodegradable Implants Combined with Immunogenic Chemotherapy and Immune Checkpoint Therapy for Peritoneal Metastatic Carcinoma Postoperative Treatment.

Si X, Ji G, Ma S, Xu Y, Zhao J, Huang Z, Zhang Y, Song W, Tang Z. Si X, et al. Among authors: xu y. ACS Biomater Sci Eng. 2020 Sep 14;6(9):5281-5289. doi: 10.1021/acsbiomaterials.0c00840. Epub 2020 Aug 11. ACS Biomater Sci Eng. 2020. PMID: 33455277

7

In-Situ-Sprayed Dual-Functional Immunotherapeutic Gel for Colorectal Cancer Postsurgical Treatment.

Si X, Ji G, Ma S, Xu Y, Zhao J, Zhang Y, Huang Z, Tang Z, Song W, Chen X. Si X, et al. Among authors: xu y. Adv Healthc Mater. 2021 Oct;10(20):e2100862. doi: 10.1002/adhm.202100862. Epub 2021 Aug 4. Adv Healthc Mater. 2021. PMID: 34347370

8

Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity.

Xu Y, Ma S, Zhao J, Chen H, Si X, Huang Z, Yu Z, Song W, Tang Z, Chen X. Xu Y, et al. Biomaterials. 2022 May;284:121489. doi: 10.1016/j.biomaterials.2022.121489. Epub 2022 Mar 25. Biomaterials. 2022. PMID: 35364489

9

Hit-and-run vaccine system that overcomes limited neoantigen epitopes for efficient broad antitumor response.

Chen H, Huang Z, Li J, Dong S, Xu Y, Ma S, Zhao J, Liu L, Sun T, Song W, Chen X. Chen H, et al. Among authors: xu y. Sci Bull (Beijing). 2024 Apr 15;69(7):922-932. doi: 10.1016/j.scib.2024.01.039. Epub 2024 Feb 1. Sci Bull (Beijing). 2024. PMID: 38331707

10

Hypoxia-sensitive supramolecular nanogels for the cytosolic delivery of ribonuclease A as a breast cancer therapeutic.

Si X, Ma S, Xu Y, Zhang D, Shen N, Yu H, Zhang Y, Song W, Tang Z, Chen X. Si X, et al. Among authors: xu y. J Control Release. 2020 Apr 10;320:83-95. doi: 10.1016/j.jconrel.2020.01.021. Epub 2020 Jan 16. J Control Release. 2020. PMID: 31954730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,735 results

Search Page

Filters